Latham-led Deal Shortlisted for the Scrip Awards’ Quris Best Partnership Alliance Honor
Healthcare and life sciences licensing and corporate deal teams advised on the transaction recognized for innovative industry collaboration.
Mark Roeder represents life sciences and technology companies at all stages of their life cycle, as well as the institutions that finance them. Mr. Roeder advises companies on strategic transactions and corporate governance matters. Specifically, he counsels clients on:
He also provides general company representation, advising executives and boards on topics such as:
Mr. Roeder frequently speaks on the IPO process and corporate governance matters.
Mr. Roeder's representative transactions include:
Healthcare and life sciences licensing and corporate deal teams advised on the transaction recognized for innovative industry collaboration.